Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DARE-BV1 in Bacterial Vaginosis
NCT04370548Phase 3Completed
- Sponsor
- Daré Bioscience, Inc.
- Start
- Jun 2020
- Primary completion
- Nov 2020
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of DARE-BV1 in bacterial vaginosis (BV), sponsored by Daré Bioscience, Inc.. Started Jun 2020; status: completed.
02
Drugs
DARE-BV1
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT04370548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04370548.